3
Total investments
1
Early stage
0
Mid stage
1
Late stage
12y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Non Executive Board Member
Aug 2019
Endopure is an emerging CBD brand focused on supply chain transparency and quality, whilst complying with all relevant Food & Cosmetic regulations.
Our brand delivers on high quality CBD products, underpinned by leading technology that provides a much needed level of transparency for our customers and the CBD industry.
Board Member
2014
Alkalon is a privately-owned Specialty Pharma company focused on developing and commercializing medicated chewing gum formulations.
The company is working in partnership with large pharmaceutical companies on dosage form development projects and has its own portfolio of nicotine gums approved for smoking cessation and smoking reduction.
Alkalon’s in-house R&D activities take place in a small non-GMP laboratory and all non-core activities are outsourced.
Experience · 11 entries
All (11)
Investments (3)
Founder (4)
Board (3)
2019
Non Executive Board Member
Aug 2019
Endopure is an emerging CBD brand focused on supply chain transparency and quality, whilst complying with all relevant Food & Cosmetic regulations.
Our brand delivers on high quality CBD products, underpinned by leading technology that provides a much needed level of transparency for our customers and the CBD industry.
2018
Co-founder & MoB, CC Pharma Nordic ApS
Apr 2018
CC Pharma is "The Original. Since 1999." Distributing only original brand-name medicinal products and delivering exclusively to pharmacies and pharmaceutical wholesalers, we have grown into a leading importer of pharmaceuticals from other EU member states into Germany.
Co-founder & CEO
2018
Lophora is a clinical-stage CNS drug discovery company developing novel, next-generation, neuroactive medicines to treat neurological and psychiatric disorders, such as depressive, anxiety, eating, and mood disorders, PTSD, and substance use disorders.
www.lophora.com
Founded in 2018 Lophora has successfully finished initial characterization of its lead-candidate LPH-5 through funding granted by the BII (Novo Nordisk Foundation), public funds and experienced biotech investors. Lophora will initiate first-in-human trials by 2024.
Efficacy of LPH-5 has been extensively characterized in vivo and has successfully completed GLP-Tox with expected CTA submission by Q2 2024.
2017
Non Executive Board Member
2017
Kibodan sells and manufactures high quality health care products sold around the whole world.
The design of the original Medidos® pill box is still almost identical to the product made by the pharmacist, Mr. Fabricius in 1967, except from a few technical improvements. Later, new products were developed to complement the product range.
Today, Kibodans products are widely used in the healthcare sector, in institutions, hospitals, nursing homes and the home care sector, as well as sold to consumers in a wide range of retail stores and pharmacies.
Our products are available in 20+ different languages and thanks to our flexible production, we are able to deliver with short notice. Our export is worldwide and the products are sold under our registered trademarks.
We appreciate the very loyal customers we have, some of which we have been dealing with for more than 45 years.
Our philosophy:
Medication compliance and faulty medication are major barriers to quality health care.
Kibodan believe in helping people manage their own medication in the simplest and safest possible way. Thats why we develop pill dispensers and health care producs that meet the highest medical standards.
"The size and structure of the box with the removable partition allows it to cover very different needs - from a single pill once a day to several pills 4 times a day" - Danish Epilepsy Association
"Personally, I know someone who uses it and he says it is clearly the best product on the market. He has tried a number of different products." - Seniorshop
”Kibodan is a stable supplier, who is always open to input from our customers, which provides good cooperation." - Abena
2016
Advisor
2016
Third Bridge is a leading global investment research firm established in 2007. With a team of over 1,500 employees worldwide dedicated to fueling decisions with expert insights. We accelerate and enhance decision-making for investors and business leaders by unearthing unique expert insights across multiple sectors, geographies, and topics. For nearly 20 years, we’ve helped clients access knowledge on demand from experts, in-person and through our Library covering over 65,000 companies.
Show all 11 entries ↓
Investment activity
2014–2019 · 3 investments
Recent (last 2 years)Earlier
